Maxnerva Technology Services Limited (HKG:1037) announced strong profits, but the stock was stagnant. Our analysis suggests that shareholders have noticed something concerning in the numbers.
See our latest analysis for Maxnerva Technology Services
SEHK:1037 Earnings and Revenue History October 6th 2022
How Do Unusual Items Influence Profit?
For anyone who wants to understand Maxnerva Technology Services' profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from CN¥18m worth of unusual items. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's as you'd expect, given these boosts are described as 'unusual'. Maxnerva Technology Services had a rather significant contribution from unusual items relative to its profit to June 2022. All else being equal, this would likely have the effect of making the statutory profit a poor guide to underlying earnings power.
Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Maxnerva Technology Services.
Our Take On Maxnerva Technology Services' Profit Performance
As we discussed above, we think the significant positive unusual item makes Maxnerva Technology Services' earnings a poor guide to its underlying profitability. As a result, we think it may well be the case that Maxnerva Technology Services' underlying earnings power is lower than its statutory profit. The good news is that, its earnings per share increased by 69% in the last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. To help with this, we've discovered 3 warning signs (1 doesn't sit too well with us!) that you ought to be aware of before buying any shares in Maxnerva Technology Services.
This note has only looked at a single factor that sheds light on the nature of Maxnerva Technology Services' profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Maxnerva科技服務有限公司(HKG:1037)公佈強勁盈利,但股價停滯不前。我們的分析表明,股東們注意到了數字中的一些令人擔憂的地方。
查看我們對Maxnerva技術服務的最新分析
聯交所:1037盈利及收入歷史2022年10月6日
不尋常的項目如何影響利潤?
對於任何想要了解Maxnerva技術服務公司超出法定數字的利潤的人來説,重要的是要注意到,在過去的12個月裏,從CN價值1800萬元的不尋常項目中獲得了法定利潤。雖然有更高的利潤總是好事,但不尋常的東西帶來的巨大貢獻有時會挫傷我們的熱情。當我們分析全球絕大多數上市公司時,我們發現重大的不尋常項目往往不會重複。考慮到這些提振被描述為“不尋常的”,這正如你所預期的那樣。Maxnerva技術服務公司在截至2022年6月的利潤中,來自不尋常項目的貢獻相當大。在其他條件不變的情況下,這可能會使法定利潤成為衡量潛在盈利能力的糟糕指標。
注:我們總是建議投資者檢查資產負債表的實力。單擊此處查看我們對Maxnerva技術服務的資產負債表分析。
我們對Maxnerva技術服務公司盈利表現的看法
正如我們上面討論的,我們認為重大的積極的不尋常項目使Maxnerva Technology Services的收益不能作為其潛在盈利能力的糟糕指南。因此,我們認為Maxnerva Technology Services的潛在盈利能力很可能低於其法定利潤。好消息是,它的每股收益在去年增長了69%。歸根結底,如果你想正確地瞭解這家公司,除了以上幾個因素之外,考慮其他因素也是至關重要的。考慮到這一點,除非我們對風險有透徹的瞭解,否則我們不會考慮投資股票。為了幫助解決這個問題,我們發現3個警示標誌(%1與我們的關係不太好!)在購買Maxnerva Technology Services的任何股票之前,您應該意識到這一點。
這份報告只關注了一個因素,它揭示了Maxnerva Technology Services的利潤性質。但還有很多其他方式可以讓你瞭解一家公司的看法。一些人認為,高股本回報率是高質量企業的良好標誌。雖然這可能需要為您做一些研究,但您可能會發現免費擁有高股本回報率的公司的集合,或者是內部人士購買的有用的股票清單。
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。